PCRX Competitors & Alternatives

Compare Pacira BioSciences, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

PCRX

Main Stock
$25.21
Tradestie Score
59
Market Cap
$1.14B
P/E Ratio
71.5
Revenue Growth
0.1%
Analyst Upside
+19.0%

Top Competitors

44 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AVDL Avadel Pharmaceuticals plc Ordinary Share
$21.64
$1.46B - 48 Compare
EVO Evotec SE American Depositary Shares
$1.60
$1.34B - 55 Compare
XERS Xeris Biopharma Holdings, Inc. Common Stock
$9.08
$1.29B - 43 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$25.43
$1.25B 15.0 37 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 48 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$22.02
$1.11B 17.2 53 Compare
CRON Cronos Group Inc. Common Share
$3.23
$1.02B 16.9 50 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.55
$711.32M - 67 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$55.36
$543.32M 133.3 61 Compare

Data updated: Oct 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

44 stocks in this industry